JP2021531268A5 - - Google Patents
Info
- Publication number
- JP2021531268A5 JP2021531268A5 JP2021500915A JP2021500915A JP2021531268A5 JP 2021531268 A5 JP2021531268 A5 JP 2021531268A5 JP 2021500915 A JP2021500915 A JP 2021500915A JP 2021500915 A JP2021500915 A JP 2021500915A JP 2021531268 A5 JP2021531268 A5 JP 2021531268A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- polypeptide
- monomer
- igg1
- antigen
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862696618P | 2018-07-11 | 2018-07-11 | |
| US62/696,618 | 2018-07-11 | ||
| PCT/US2019/041406 WO2020014486A1 (en) | 2018-07-11 | 2019-07-11 | Compositions and methods related to engineered fc-antigen binding domain constructs |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021531268A JP2021531268A (ja) | 2021-11-18 |
| JPWO2020014486A5 JPWO2020014486A5 (https=) | 2022-07-14 |
| JP2021531268A5 true JP2021531268A5 (https=) | 2022-07-14 |
Family
ID=69142016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021500915A Withdrawn JP2021531268A (ja) | 2018-07-11 | 2019-07-11 | 改変されたＦｃ抗原結合ドメイン構築体に関する組成物および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220267460A1 (https=) |
| EP (1) | EP3820519A4 (https=) |
| JP (1) | JP2021531268A (https=) |
| KR (1) | KR20210042326A (https=) |
| CN (1) | CN113164591A (https=) |
| AU (1) | AU2019302740A1 (https=) |
| BR (1) | BR112021000392A2 (https=) |
| CA (1) | CA3106212A1 (https=) |
| IL (1) | IL279998A (https=) |
| MX (1) | MX2021000287A (https=) |
| WO (1) | WO2020014486A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX386014B (es) | 2016-08-10 | 2025-03-18 | Univ Ajou Ind Academic Coop Found | Citocina fusionada a fc heterodimérico, y composición farmacéutica que comprende la misma. |
| AU2018308088B2 (en) | 2017-07-25 | 2025-05-29 | Truebinding, Inc. | Treating cancer by blocking the interaction of TIM-3 and its ligand |
| AU2019366956B2 (en) * | 2018-10-23 | 2025-10-30 | Dragonfly Therapeutics, Inc. | Heterodimeric Fc-fused proteins |
| AU2020214796A1 (en) | 2019-01-30 | 2021-07-29 | Truebinding, Inc. | Anti-Gal3 antibodies and uses thereof |
| WO2021242776A2 (en) | 2020-05-26 | 2021-12-02 | Truebinding, Inc. | Methods of treating inflammatory diseases by blocking galectin-3 |
| KR20240114791A (ko) * | 2021-11-05 | 2024-07-24 | 오슬로 유니버시테시케후스 에이치에프 | IgA Fc 및 IgG Fc 이중 단백질 구조 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080311034A1 (en) * | 2007-04-30 | 2008-12-18 | Anderson Glenn M | Anti-Tissue Factor Antibodies and Compositions with Enhanced Effector Function |
| CN101835802B (zh) * | 2007-06-01 | 2014-04-09 | 马里兰大学巴尔的摩分校 | 免疫球蛋白恒定区Fc受体结合剂 |
| EP2748197A2 (en) * | 2011-08-26 | 2014-07-02 | Merrimack Pharmaceuticals, Inc. | Tandem fc bispecific antibodies |
| JP2015527366A (ja) * | 2012-08-20 | 2015-09-17 | グリックニック インコーポレイテッド | 抗原結合および多価ｆｃガンマ受容体結合活性を有する分子 |
| UA117289C2 (uk) * | 2014-04-02 | 2018-07-10 | Ф. Хоффманн-Ля Рош Аг | Мультиспецифічне антитіло |
| JP2017518965A (ja) * | 2014-05-02 | 2017-07-13 | モメンタ ファーマシューティカルズ インコーポレイテッ | エンジニアリングされたＦｃ構築物に関連する組成物および方法 |
| BR112018074056A2 (pt) * | 2016-05-23 | 2019-03-06 | Momenta Pharmaceuticals, Inc. | composições e métodos relacionados a construtos de fc manipulados |
| RU2019124709A (ru) * | 2017-01-06 | 2021-02-08 | Момента Фармасьютикалз, Инк. | КОМПОЗИЦИИ И СПОСОБЫ, СВЯЗАННЫЕ СО СКОНСТРУИРОВАННЫМИ КОНСТРУКЦИЯМИ НА ОСНОВЕ Fc-АНТИГЕНСВЯЗЫВАЮЩЕГО ДОМЕНА |
-
2019
- 2019-07-11 US US17/259,480 patent/US20220267460A1/en not_active Abandoned
- 2019-07-11 BR BR112021000392-4A patent/BR112021000392A2/pt not_active IP Right Cessation
- 2019-07-11 WO PCT/US2019/041406 patent/WO2020014486A1/en not_active Ceased
- 2019-07-11 KR KR1020217004248A patent/KR20210042326A/ko not_active Ceased
- 2019-07-11 JP JP2021500915A patent/JP2021531268A/ja not_active Withdrawn
- 2019-07-11 CA CA3106212A patent/CA3106212A1/en active Pending
- 2019-07-11 EP EP19834503.5A patent/EP3820519A4/en not_active Withdrawn
- 2019-07-11 AU AU2019302740A patent/AU2019302740A1/en not_active Abandoned
- 2019-07-11 MX MX2021000287A patent/MX2021000287A/es unknown
- 2019-07-11 CN CN201980059576.6A patent/CN113164591A/zh active Pending
-
2021
- 2021-01-07 IL IL279998A patent/IL279998A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021531268A5 (https=) | ||
| IL261674A (en) | Protein-like binding proteins with a double variable region have a cross-linking region direction | |
| RU2019124709A (ru) | КОМПОЗИЦИИ И СПОСОБЫ, СВЯЗАННЫЕ СО СКОНСТРУИРОВАННЫМИ КОНСТРУКЦИЯМИ НА ОСНОВЕ Fc-АНТИГЕНСВЯЗЫВАЮЩЕГО ДОМЕНА | |
| JP2020531438A5 (ja) | Ｎｋｇ２ｄ、ｃｄ１６、およびｈｌａ−ｅに結合するタンパク質 | |
| JP2021098732A5 (https=) | ||
| JP2019534277A5 (https=) | ||
| Carter | Bispecific human IgG by design | |
| JP2018046872A5 (https=) | ||
| FI3392276T3 (fi) | Heterodimeerimolekyyli, joka perustuu rakenteelliseen CH3-domeeniin, sekä menetelmä sen valmistamiseksi ja sen käyttö | |
| IL299221A (en) | Cd3 binding antibodies | |
| FI3529269T3 (fi) | Vasta-ainerakenteita | |
| FI3749346T3 (fi) | Nkg2d-reseptoriin kohdistuvat vasta-aineen vaihtelevan domeenin yhdistelmät | |
| HRP20211528T1 (hr) | Trispecifični i/ili trovalentni vezujući proteini za prevenciju ili liječenje hiv infekcije | |
| JP2021533159A5 (https=) | ||
| JP2020514301A5 (https=) | ||
| JP2020507328A5 (https=) | ||
| JP2021094022A5 (https=) | ||
| JP2018527903A5 (https=) | ||
| JP2018522541A5 (https=) | ||
| HRP20150444T1 (hr) | Trovalentna, bispecifiäśna protutijela | |
| RU2011148913A (ru) | Иммуноглобулин с двумя вариабельными доменами и его применение | |
| RU2019129511A (ru) | Белки, связывающие gd2, nkg2d и cd16 | |
| JP2021532085A5 (https=) | ||
| JP2017534644A5 (https=) | ||
| JP2021521781A5 (https=) |